Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/18/2014 | US20140271605 Stable bioactive substances and methods of making |
09/18/2014 | US20140271601 Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use |
09/18/2014 | US20140271599 Product and process for mucus viscosity normalization |
09/18/2014 | US20140271598 Methods and compositions for cns delivery of iduronate-2-sulfatase |
09/18/2014 | US20140271597 Treatment of ophthalmic conditions |
09/18/2014 | US20140271589 Treatment of collagen defects using protein solutions |
09/18/2014 | US20140271588 Treatment of peripheral vascular disease using protein solutions |
09/18/2014 | US20140271587 Treatment of inflammatory respiratory disease using biological solutions |
09/18/2014 | US20140271586 Nutritional Composition Containing a Peptide Component with Adiponectin Simulating Properties and Uses Thereof |
09/18/2014 | US20140271558 Dietary Supplements Including Glucan and Fulvic Acid |
09/18/2014 | US20140271555 Activating adiponectin by casein hydrolysate |
09/18/2014 | US20140271554 Reducing Proinflammatory Response |
09/18/2014 | US20140271553 Nutritional Compositions Containing A Peptide Component with Anti-Inflammatory Properties and Uses Thereof |
09/18/2014 | US20140271552 Nutritional Compositions Containing a Peptide Component and Uses Thereof |
09/18/2014 | US20140271549 Use of Antibiotics to Enhance Treatment With Therapeutic Viruses |
09/18/2014 | US20140271544 Combination therapy for treating hcv infection in specific patient subgenotype sub-population |
09/18/2014 | US20140271543 Pyridin-2(1h)-one derivatives as jak inhibitors |
09/18/2014 | US20140271541 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
09/18/2014 | US20140271539 Novel use of members of il-10 cytokine family |
09/18/2014 | US20140271488 Chiral compounds of varying conformational rigidity and methods of synthesis |
09/18/2014 | US20140271487 Prussian blue-inspired constructs for multimodal imaging and therapy |
09/18/2014 | US20140271479 Optogenetic control of inputs to the ventral tegmental area |
09/18/2014 | US20140271471 Thermo-sensitive bone growth compositions |
09/18/2014 | US20140260098 Method and system for producing high purity vancomycin hydrochloride |
09/17/2014 | EP2777710A1 Methods for administering anti-IL-5 antibodies |
09/17/2014 | EP2777695A1 Formulations for a tight junction effector |
09/17/2014 | EP2776471A1 Stable peptide-based furin inhibitors |
09/17/2014 | EP2776457A1 Neurotoxins exhibiting shortened biological activity |
09/17/2014 | EP2776455A1 Channelrhodopsins for optical control of cells |
09/17/2014 | EP2776453A1 Process of purification of teicoplanin |
09/17/2014 | EP2776452A1 Process of purification of teicoplanin |
09/17/2014 | EP2776451A1 Cyclin a1-targeted t-cell immunotherapy for cancer |
09/17/2014 | EP2776129A1 Calcimimetics and methods for their use |
09/17/2014 | EP2776066A1 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
09/17/2014 | EP2776064A1 Provasopressin antagonists and uses thereof |
09/17/2014 | EP2776059A2 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases |
09/17/2014 | EP2776058A1 Apotransferrin for the treatment of brain stroke |
09/17/2014 | EP2776057A1 Methods of cardiac repair |
09/17/2014 | EP2776056A1 Novel composition for gene delivery |
09/17/2014 | EP2776055A1 Treatments for gastrointestinal disorders |
09/17/2014 | EP2776054A2 Antagonists for abnormal vasopressin v2 receptor and uses thereof |
09/17/2014 | EP2776053A1 Methods and compositions for treating pain |
09/17/2014 | EP2776052A1 Methods and compositions for wound treatment |
09/17/2014 | EP2776051A1 Therapeutic combinations and methods of treating melanoma |
09/17/2014 | EP2776043A1 Biomarkers of response to proteasome inhibitors |
09/17/2014 | EP2775874A1 Pharmaceutical composition for the prevention and the treatment of degenerative skin disorders especially caused by ionizing radiations |
09/16/2014 | USRE45137 Adjuvanted meningococcus compositions |
09/16/2014 | US8835617 Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same |
09/16/2014 | US8835613 β-mannosylceramide and stimulation of NKT cell anti-tumor immunity |
09/16/2014 | US8835608 Anti-MRP3 antibodies and methods of use |
09/16/2014 | US8835605 Uses of cancer-targeting peptides in cancer diagnosis |
09/16/2014 | US8835604 Antimicrobial peptide variants and polynucleotides encoding same |
09/16/2014 | US8835603 Agents for the treatment of celiac disease |
09/16/2014 | US8835601 Natriuretic polypeptide delivery systems |
09/16/2014 | US8835513 Drug delivery devices |
09/16/2014 | US8835467 SIR2 regulation |
09/16/2014 | US8835466 Synthesis and uses of pyroglutamic acid derivatives |
09/16/2014 | US8835448 Methods and formulations for modulating lyn kinase activity and treating related disorders |
09/16/2014 | US8835401 Treatment of cancer by inhibition of IGFBPs and clusterin |
09/16/2014 | US8835398 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
09/16/2014 | US8835395 Protein peptide hydrogels |
09/16/2014 | US8835394 Treatment for basal cell carcinoma |
09/16/2014 | US8835393 Inhibitors of IAP |
09/16/2014 | US8835392 Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors |
09/16/2014 | US8835391 Alpha B-crystallin as a therapy for multiple sclerosis |
09/16/2014 | US8835389 Use of calcitonin for the treatment of RA |
09/16/2014 | US8835387 Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases |
09/16/2014 | US8835386 Activity of recombinant equine follicle stimulating hormone |
09/16/2014 | US8835385 FGF21 polypeptides comprising two or more mutations and uses thereof |
09/16/2014 | US8835384 Compositions and methods for obtaining cells to treat heart tissue |
09/16/2014 | US8835383 Method for controlling the digestive coagulation of proteins |
09/16/2014 | US8835382 Lipopeptide compositions and related methods |
09/16/2014 | US8835379 Derivatives of CGRP |
09/16/2014 | US8835378 Multi-domain amphipathic helical peptides and methods of their use |
09/16/2014 | US8835377 Oral delivery of peptide pharmaceutical compositions |
09/16/2014 | US8835376 Process for making particles for delivery of drug nanoparticles |
09/16/2014 | US8835375 Cyclic angiotensin analogs |
09/16/2014 | US8835361 High-throughput quantitation of crop seed proteins |
09/16/2014 | US8835172 Modular functional peptides for delivery of nanoparticles |
09/16/2014 | US8835170 Methods and compositions useful for diabetic wound healing |
09/16/2014 | US8835145 Thrombolytic enzyme and a process for its preparation |
09/16/2014 | US8835144 Dual-functional nonfouling surfaces comprising target binding partner covalently coupled to polymer attached to substrate |
09/16/2014 | US8835107 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
09/16/2014 | US8834926 Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels |
09/16/2014 | US8834920 Liposome composition for targeting egfr receptor |
09/16/2014 | US8834900 Combination motif immune stimulatory oligonucleotides with improved activity |
09/16/2014 | US8834898 Cholera toxin chimera and its use as a staph vaccine |
09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
09/16/2014 | US8834887 Drug for suppressing pathogen occurring in vivo |
09/16/2014 | US8834879 Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis |
09/16/2014 | US8834876 Therapeutic agent for hematopoietic tumors |
09/16/2014 | US8834874 Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS |
09/16/2014 | US8834869 Pharmacological vitreolysis |
09/16/2014 | US8834868 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
09/16/2014 | US8834867 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
09/16/2014 | US8834865 Delivery system for co-formulated enzyme and substrate |
09/16/2014 | US8834840 Magnetic resonance imaging of self-assembled biomaterial scaffolds |
09/16/2014 | US8833363 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
09/16/2014 | US8833306 PACAP for aquatic organism culture |
09/16/2014 | CA2787097C Low viscosity liquid polymeric delivery system |